EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting apoptotic pathways for cancer therapy

Xiaobing Tian, Praveen R Srinivasan, Vida Tajiknia, Ashley F Sanchez Sevilla Uruchurtu, Attila A Seyhan, Benedito A Carneiro, Arielle De La Cruz, Maximilian Pinho-Schwermann, Andrew George, Shuai Zhao, Jillian Strandberg, Francesca Di Cristofano und 9 weitere

Journal of Clinical Investigation · 15.07.2024 · 134 (14)

DOI: 10.1172/jci179570 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.07.2024. Verfasst von Xiaobing Tian und 20 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Translational Oncology and Experimental Cancer Therapeutics and. Hauptthemen laut MEDLINE: Neoplasms, Apoptosis, Tumor Suppressor Protein p53, Signal Transduction. Die Arbeit wurde bisher 146-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apoptosis is a form of programmed cell death that is mediated by intrinsic and extrinsic pathways. Dysregulation of and resistance to cell death are hallmarks of cancer. For over three decades, the development of therapies to promote treatment of cancer by inducing various cell death modalities, including apoptosis, has been a main goal of clinical oncology. Apoptosis pathways also interact with other signaling mechanisms, such as the p53 signaling pathway and the integrated stress response (ISR) pathway. In addition to agents directly targeting the intrinsic and extrinsic pathway components, anticancer drugs that target the p53 and ISR signaling pathways are actively being developed. In this Review, we discuss selected and promising anticancer therapies in various stages of development, including drug targets, mechanisms, and resistance to related treatments, focusing especially on B cell lymphoma 2 (BCL-2) inhibitors, TRAIL analogues, DR5 antibodies, and strategies that target p53, mutant p53, and the ISR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsApoptosisTumor Suppressor Protein p53Signal TransductionHumansAnimalsAntineoplastic AgentsProto-Oncogene Proteins c-bcl-2

Substanzen

Tumor Suppressor Protein p53TP53 protein, humanAntineoplastic AgentsProto-Oncogene Proteins c-bcl-2BCL2 protein, human

Autor:innen und Institutionen

  • Laboratory of Translational Oncology and Experimental Cancer Therapeutics and.
  • Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
  • Joint Program in Cancer Biology, Lifespan Health System and Brown University, Providence, Rhode Island, USA.
  • Legorreta Cancer Center at Brown University, Providence, Rhode Island, USA.
  • Pathobiology Graduate Program, Brown University, Providence, Rhode Island, USA.
  • Hematology/Oncology Division, Department of Medicine, Lifespan Health System and Brown University, Providence, Rhode Island, USA.

Zitieren

APA

Tian, X., Srinivasan, P. R., Tajiknia, V., Sanchez Sevilla Uruchurtu, A. F., Seyhan, A. A., Carneiro, B. A., De La Cruz, A., Pinho-Schwermann, M., George, A., Zhao, S., Strandberg, J., Di Cristofano, F., Zhang, S., Zhou, L., Raufi, A. G., Navaraj, A., Zhang, Y., Verovkina, N., Ghandali, M., …, & El-Deiry, W. S. (2024). Targeting apoptotic pathways for cancer therapy. Journal of Clinical Investigation, 134(14). https://doi.org/10.1172/jci179570

Vancouver

Tian X, Srinivasan PR, Tajiknia V, Sanchez Sevilla Uruchurtu AF, Seyhan AA, Carneiro BA, et al. Targeting apoptotic pathways for cancer therapy. Journal of Clinical Investigation. 2024;134(14). doi:10.1172/jci179570

BibTeX
@article{Tian2024,
  author = {Tian, Xiaobing and Srinivasan, Praveen R and Tajiknia, Vida and Sanchez Sevilla Uruchurtu, Ashley F and Seyhan, Attila A and Carneiro, Benedito A and De La Cruz, Arielle and Pinho-Schwermann, Maximilian and George, Andrew and Zhao, Shuai and Strandberg, Jillian and Di Cristofano, Francesca and Zhang, Shengliang and Zhou, Lanlan and Raufi, Alexander G and Navaraj, Arunasalam and Zhang, Yiqun and Verovkina, Nataliia and Ghandali, Maryam and Ryspayeva, Dinara and El-Deiry, Wafik S},
  title = {Targeting apoptotic pathways for cancer therapy},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {14},
  doi = {10.1172/jci179570}
}
Kostenlos starten →